U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C23H32N2O6
Molecular Weight 432.51
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of ENCIPRAZINE

SMILES

COC1=CC(OCC(O)CN2CCN(CC2)C3=C(OC)C=CC=C3)=CC(OC)=C1OC

InChI

InChIKey=KSQCNASWXSCJTD-UHFFFAOYSA-N
InChI=1S/C23H32N2O6/c1-27-20-8-6-5-7-19(20)25-11-9-24(10-12-25)15-17(26)16-31-18-13-21(28-2)23(30-4)22(14-18)29-3/h5-8,13-14,17,26H,9-12,15-16H2,1-4H3

HIDE SMILES / InChI

Molecular Formula C23H32N2O6
Molecular Weight 432.51
Charge 0
Count
Stereochemistry RACEMIC
Additional Stereochemistry No
Defined Stereocenters 0 / 1
E/Z Centers 0
Optical Activity ( + / - )

Enciprazine also known as WY-48624 or, D-3112 is a GABA A receptor agonist which was in the phase III of clinical trial for the treatment of anxiety disorders. Enciprazine was well tolerated, with low levels of sedative and asthenic side effects reported. However, research was discontinued.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Unknown

Approved Use

Unknown
Overview

Overview

CYP3A4CYP2C9CYP2D6hERG



OverviewOther

Other InhibitorOther SubstrateOther Inducer

Drug as perpetrator​

Drug as perpetrator​

Drug as victim

Drug as victim

TargetModalityActivityMetaboliteClinical evidence
yes
PubMed

PubMed

TitleDatePubMed
Early phase-II semi double-blind study of the new alkaline propanolamine derivative enciprazine (short communication).
1988 Jun
Comparison of changes in the EEG of freely moving rats induced by enciprazine, buspirone and diazepam.
1989 Aug
Chemistry and pharmacology of the non-benzodiazepine anxiolytic enciprazine and related compounds.
1990 Nov
Patents

Patents

Sample Use Guides

5-week, double-blind trial comparing three dose strengths of enciprazine (5 mg t.i.d., 10 mg t.i.d., and 20 mg t.i.d.) to placebo. A dose escalation was permitted after 2 weeks of active drug treatment, which 61 percent of patients overall took advantage of.
Route of Administration: Oral
In Vitro Use Guide
Unknown
Substance Class Chemical
Created
by admin
on Fri Dec 15 15:33:18 UTC 2023
Edited
by admin
on Fri Dec 15 15:33:18 UTC 2023
Record UNII
L6X660925G
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
ENCIPRAZINE
INN   MI  
INN  
Official Name English
(±)-4-(O-METHOXYPHENYL)-.ALPHA.-((3,4,5-TRIMETHOXYPHENOXY)METHYL)-1-PIPERAZINEETHANOL
Common Name English
1-PIPERAZINEETHANOL, 4-(2-METHOXYPHENYL)-.ALPHA.-((3,4,5-TRIMETHOXYPHENOXY)METHYL)-, (±)-
Systematic Name English
ENCIPRAZINE [MI]
Common Name English
enciprazine [INN]
Common Name English
(±)-1-(3-(3,4,5-TRIMETHOXYPHENOXY)-2-HYDROXYPROPYL)-4-(2-METHOXYPHENYL)PIPERAZINE
Systematic Name English
4-(2-METHOXYPHENYL)-A-((3,4,5-TRIMETHOXYPHENOXY)METHYL)-1-PIPERAZINEETHANOL
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C28197
Created by admin on Fri Dec 15 15:33:18 UTC 2023 , Edited by admin on Fri Dec 15 15:33:18 UTC 2023
Code System Code Type Description
SMS_ID
100000080205
Created by admin on Fri Dec 15 15:33:18 UTC 2023 , Edited by admin on Fri Dec 15 15:33:18 UTC 2023
PRIMARY
NCI_THESAURUS
C73209
Created by admin on Fri Dec 15 15:33:18 UTC 2023 , Edited by admin on Fri Dec 15 15:33:18 UTC 2023
PRIMARY
INN
4820
Created by admin on Fri Dec 15 15:33:18 UTC 2023 , Edited by admin on Fri Dec 15 15:33:18 UTC 2023
PRIMARY
EPA CompTox
DTXSID3057806
Created by admin on Fri Dec 15 15:33:18 UTC 2023 , Edited by admin on Fri Dec 15 15:33:18 UTC 2023
PRIMARY
ChEMBL
CHEMBL101284
Created by admin on Fri Dec 15 15:33:18 UTC 2023 , Edited by admin on Fri Dec 15 15:33:18 UTC 2023
PRIMARY
MERCK INDEX
m717
Created by admin on Fri Dec 15 15:33:18 UTC 2023 , Edited by admin on Fri Dec 15 15:33:18 UTC 2023
PRIMARY Merck Index
CAS
68576-86-3
Created by admin on Fri Dec 15 15:33:18 UTC 2023 , Edited by admin on Fri Dec 15 15:33:18 UTC 2023
PRIMARY
EVMPD
SUB06520MIG
Created by admin on Fri Dec 15 15:33:18 UTC 2023 , Edited by admin on Fri Dec 15 15:33:18 UTC 2023
PRIMARY
FDA UNII
L6X660925G
Created by admin on Fri Dec 15 15:33:18 UTC 2023 , Edited by admin on Fri Dec 15 15:33:18 UTC 2023
PRIMARY
WIKIPEDIA
Enciprazine
Created by admin on Fri Dec 15 15:33:18 UTC 2023 , Edited by admin on Fri Dec 15 15:33:18 UTC 2023
PRIMARY
MESH
C057238
Created by admin on Fri Dec 15 15:33:18 UTC 2023 , Edited by admin on Fri Dec 15 15:33:18 UTC 2023
PRIMARY
PUBCHEM
50222
Created by admin on Fri Dec 15 15:33:18 UTC 2023 , Edited by admin on Fri Dec 15 15:33:18 UTC 2023
PRIMARY
Related Record Type Details
ENANTIOMER -> RACEMATE
ENANTIOMER -> RACEMATE
SALT/SOLVATE -> PARENT
Related Record Type Details
ACTIVE MOIETY